Laura Chico
Stock Analyst at Wedbush
Total Price Targets
20
Stocks Covered
13
Sectors
Healthcare
Most Recent
Apr 8, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Laura Chico
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc. | $31.00 | $13.41 | +131.2% | 1 | Apr 8, 2026 |
| LRMR | Larimar Therapeutics, Inc. | $12.00 | $3.98 | +201.9% | 2 | Mar 3, 2026 |
| BIIB | Biogen Inc. | $187.00 | $186.69 | +0.2% | 5 | Feb 10, 2026 |
| VERA | Vera Therapeutics, Inc. | $33.00 | $35.31 | -6.6% | 2 | Dec 11, 2025 |
| DNLI | Denali Therapeutics Inc. | $30.00 | $18.49 | +62.2% | 2 | Dec 11, 2025 |
| MAZE | Maze Therapeutics, Inc. | $17.00 | $27.23 | -37.6% | 1 | Jul 8, 2025 |
| XENE | Xenon Pharmaceuticals Inc. | $49.00 | $56.81 | -13.7% | 1 | Aug 9, 2024 |
| VYGR | Voyager Therapeutics, Inc. | $8.00 | $3.75 | +113.0% | 1 | May 14, 2024 |
| PHVS | Pharvaris N.V. | $27.00 | $29.04 | -7.0% | 1 | Sep 25, 2023 |
| ARDX | Ardelyx, Inc. | $2.00 | $6.93 | -71.2% | 1 | Dec 29, 2022 |
| APLS | Apellis Pharmaceuticals, Inc. | $28.00 | $40.95 | -31.6% | 1 | Nov 9, 2021 |
| RARE | Ultragenyx Pharmaceutical Inc. | $92.00 | $24.79 | +271.2% | 1 | Nov 3, 2021 |
| NBIX | Neurocrine Biosciences, Inc. | $112.00 | $131.64 | -14.9% | 1 | Aug 4, 2021 |
Recent Activity
- Apr 8, 2026— Set$31.00price target onVRDN(Viridian Therapeutics, Inc.)
- Mar 3, 2026— Set$12.00price target onLRMR(Larimar Therapeutics, Inc.)
- Feb 10, 2026— Set$187.00price target onBIIB(Biogen Inc.)
- Dec 11, 2025— Set$30.00price target onDNLI(Denali Therapeutics Inc.)
- Dec 11, 2025— Set$33.00price target onVERA(Vera Therapeutics, Inc.)
- Dec 5, 2025— Set$31.00price target onDNLI(Denali Therapeutics Inc.)
- Jul 8, 2025— Set$17.00price target onMAZE(Maze Therapeutics, Inc.)
- Oct 3, 2024— Set$22.00price target onLRMR(Larimar Therapeutics, Inc.)
- Sep 23, 2024— Set$205.00price target onBIIB(Biogen Inc.)
- Aug 9, 2024— Set$49.00price target onXENE(Xenon Pharmaceuticals Inc.)
- May 14, 2024— Set$8.00price target onVYGR(Voyager Therapeutics, Inc.)
- Apr 25, 2024— Set$215.00price target onBIIB(Biogen Inc.)
- Mar 21, 2024— Set$34.00price target onVERA(Vera Therapeutics, Inc.)
- Sep 25, 2023— Set$27.00price target onPHVS(Pharvaris N.V.)
- Aug 7, 2023— Set$269.00price target onBIIB(Biogen Inc.)
- Dec 29, 2022— Set$2.00price target onARDX(Ardelyx, Inc.)
- Apr 9, 2022— Set$185.00price target onBIIB(Biogen Inc.)
- Nov 9, 2021— Set$28.00price target onAPLS(Apellis Pharmaceuticals, Inc.)
- Nov 3, 2021— Set$92.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
- Aug 4, 2021— Set$112.00price target onNBIX(Neurocrine Biosciences, Inc.)
Frequently Asked Questions
Who is Laura Chico?
Laura Chico is a stock analyst at Wedbush covering 13 stocks primarily in Healthcare. They have issued 20 price targets since Aug 4, 2021.
What stocks does Laura Chico cover?
Laura Chico currently covers 13 stocks, including BIIB, LRMR, VERA, DNLI, VRDN.
What is Laura Chico's latest price target?
Laura Chico's most recent price target was $31.00 on VRDN (Viridian Therapeutics, Inc.), set on Apr 8, 2026.
What is Laura Chico's highest price target?
Laura Chico's highest issued price target is $269.00 on BIIB, set on Aug 7, 2023.
More Analysts at Wedbush
Coverage based on publicly published price targets. Not investment advice.